Articles tagged with Type 1 Diabetes
A new study found that vitamin C and E supplements do not prevent pre-eclampsia in pregnant women with type 1 diabetes, but may benefit those with low antioxidant status. The supplement did not cause harm to mothers or babies.
A study found that high HDL levels in women with type 1 diabetes increased the risk of heart disease, while low levels actually decreased risk. The researchers suggest that too much good cholesterol may not always be protective and could even be harmful.
Researchers developed an experimental cure for Type 1 diabetes using gene therapy, which successfully reversed the disease in about half of nonobese diabetic mice. The treatment protected new beta cells from autoimmune attack by adding a protective gene, allowing them to function normally.
Researchers have discovered that type 1 diabetes patients experience a 10-fold increase in islet cell replication after diagnosis. This finding suggests that immune cells are involved in triggering the replication process. The study offers promising results for developing a therapy to encourage beta cells to reproduce and produce insulin.
Researchers have found a statistically significant association between enteroviral infection and diagnosis of type-1 diabetes in children, with 83% of patients testing positive for enteroviral DNA. The study suggests that different enterovirus types may represent a significant biomarker for early-stage juvenile diabetes.
Researchers found a molecular link between genetic mutations and type 1 diabetes, identifying a critical new target for intervention. The study's findings suggest a way to break 'tolerance' in the immune system, potentially leading to novel antibody or small molecule therapies.
Researchers developed a nanovaccine to stop aggressive immune attack on beta cells, restoring normal blood sugar levels in humanized mouse models. The treatment targeted specific immune cells without compromising the rest of the immune system.
A new study found that teenagers with type 1 diabetes are more likely to adhere to their treatment plan if their parents monitor their care and maintain a positive parent-adolescent relationship. The study revealed a decline in parental involvement as the adolescent grows older, which relates to decreased adherence to treatment.
Scientists found that alpha cells can spontaneously reprogram into beta cells, restoring insulin production and potentially treating type 1 diabetes. The study demonstrated that removing nearly all beta cells allowed the pancreas to regenerate new ones, offering a new strategy for regenerating insulin-producing cells.
Researchers at EVMS Strelitz Diabetes Center have received a $1.076 million grant from the Department of Defense to develop new treatments for Type 1 diabetes, focusing on regeneration of insulin-producing beta cells and neutralizing the immune system's attack. The goal is to create a functional cure using a combination therapy regimen.
Researchers at UT Southwestern Medical Center found that leptin administration showed better management of blood-sugar variability and lipogenesis, the conversion of simple sugars into fatty acids. Leptin therapy also reduced food intake and increased lean body mass in non-obese type 1 diabetic mice.
Researchers found that some genes have opposing effects on the risk of developing both autoimmune diseases, while others may increase the risk for both. The study suggests a possible genetic switch that could be triggered by specific infectious agents.
Researchers at the University of Cambridge found that first-generation artificial pancreas systems can lower risk of low blood sugar emergencies while sleeping and improve diabetes control. The study showed improved target blood glucose levels, minimized low blood sugars, and reduced hypoglycemia.
A new study published by researchers at Eastern Virginia Medical School has identified a protein-based enzyme called 12-Lipoxygenase (12-LO) as a key player in the development of Type 1 diabetes. The enzyme produces specific lipids that cause inflammation and lead to beta cell death, highlighting a potential target for new therapies.
Scientists at the University of Cambridge have developed a new algorithm that significantly improves glucose control and reduces the risk of hypoglycemia in children with type 1 diabetes. The study shows that using an artificial pancreas system overnight can halve the time blood glucose levels fall below 3.9mmol/l, while sleeping.
Researchers at the Salk Institute for Biological Studies have made a breakthrough in understanding how stress hormones affect insulin-producing cells. The study found that the hormone CRF can increase the rate of cell growth and proliferation, which could potentially lead to new approaches for treating type 1 diabetes.
Research finds that African-American patients with type 1 diabetes who consume more calories and sodium are more likely to develop vision-threatening retinopathy. Low caloric and sodium intakes may have a beneficial effect on the progression of diabetic retinopathy in this population.
Researchers found that injections of rituximab slowed beta cell destruction in patients with newly diagnosed type 1 diabetes, suggesting a potential treatment option. The study suggests targeting B cells may improve beta-cell function in early type 1 diabetes.
A study found that insulin resistance in adolescents with type 1 diabetes affects heart and vessel function, as well as exercise capacity. The research suggests that addressing insulin resistance early on may help decrease cardiovascular morbidity and mortality in this population.
A Swedish study found that pregnant women who eat vegetables daily have a lower risk of their child developing type 1 diabetes. The study analyzed data from almost 6,000 five-year-olds and found that those whose mothers rarely ate vegetables had a higher risk.
A new gene data tool has achieved greater accuracy than conventional methods in assessing individual risk for type 1 diabetes. By analyzing a large set of gene markers, the tool identifies a large ensemble of genes that interact together to predict disease risk.
Researchers discovered that T cells recognize a specific marker on insulin-producing cells to gain access to the islets, triggering inflammation and destruction. The findings suggest new approaches to halt or prevent type I diabetes by blocking T cell entry into the islets.
Research highlights improved vision in type 1 diabetes patients, a link between macular degeneration and coronary heart disease, and the impact of vision on well-being across the lifespan. Effective treatments and better management of blood glucose levels contribute to the positive trend.
A recent study found inhaled insulin to be inferior to traditional insulin injections in maintaining optimal blood glucose levels. Despite this setback, researchers continue to explore alternative routes of insulin delivery, including MannKind Corporation's Technosphere Insulin.
The study found that regular CGM use is the primary factor in achieving better diabetes control, regardless of age. People using CGM devices six days per week or more showed similar levels of improvement in diabetes control across all age groups, from children to adults.
Scientists at Eastern Virginia Medical School have identified a vital step in the development of Type 1 diabetes and hope to develop a novel therapeutic approach by blocking an enzyme called 12-LO. Preliminary results are promising, and further research is underway.
Scientists have discovered a potential clue to type 1 diabetes causes, finding that nearly half of patients have an abnormal immune response to wheat proteins. The over-reaction is linked to genes associated with the disease and may contribute to other immune problems.
Scientists at Stanford University have identified a gene variant that may play a role in the development of type 1 diabetes. The study found that cells in the pancreatic lymph nodes produce two forms of the Deaf1 gene, one functional and one nonfunctional. Increased levels of the nonfunctional variant were found in people with type 1 d...
Scientists have discovered a way to regenerate insulin-producing beta cells from non-insulin-producing alpha cells, offering new hope for treating type 1 diabetes. The research found that modifying the expression of a specific gene in alpha cells can drive their conversion into functional beta cells.
A study published in the Archives of Internal Medicine found that intensive glucose control halves the rate of eye and kidney damage in people with longstanding type 1 diabetes. The study also showed lower rates of cardiovascular disease events and improved vision loss rates compared to conventional control.
Researchers analyzed data from studies on type 1 diabetes to find that intensive treatment can significantly reduce the risk of complications. The study showed improved outcomes in patients treated with more intensive therapy.
A treatment that significantly slows the progression of eye injury in people with type 1 diabetes has been found. The treatment uses an antihypertensive medication commonly prescribed to treat high blood pressure, and was shown to slow diabetic eye damage in over 65% of participants.
A recent major study has found that children and young people with type 1 diabetes are more likely to be overweight or obese than those without diabetes. The research, which compared data from over 11,000 children and youths, also highlights significant differences in weight problems among different racial and ethnic groups.
Researchers found that a combination of insulin and vitamin C stopped blood vessel damage caused by Type 1 diabetes in patients with poor glucose control. The therapy's effectiveness was proven in humans for the first time, offering hope for diabetic patients to avoid complications.
According to a new study, type 1 diabetes cases in children under five years are expected to double by 2020 if current trends continue. The researchers found an overall increase of 3.9% per year, with the highest rates seen in children under 5 and those between 10-14 years old.
A study found that continuous glucose monitoring (CGM) devices enable people with excellent blood sugar control to continue managing their diabetes while reducing the frequency of low blood sugar events. CGM devices helped participants spend more time in the target blood sugar range and reduced biochemical hypoglycemia.
Researchers have identified the protein ILK as promoting growth of aggressive rhabdomyosarcoma cells and suppressing ERMS cell growth. A therapy targeting ILK may provide a tailored approach for treating the lethal form of RMS, ARMS.
A study published in The Journal of Pediatrics found that telemedicine improves diabetes care for school children with better blood sugar control and reduced hospital visits. School nurses who used the program reported improved patient outcomes, including increased patient satisfaction and completed tasks related to their diabetes care.
A study of nearly 6,900 patients found that simultaneous pancreas-kidney (SPK) transplantation resulted in a 89% long-term survival rate compared to 80% for kidney-only transplants and 65% for deceased donor transplants. SPK recipients were also more likely to die during the first year after transplantation.
Researchers found that blocking a hormone called BAFF can prevent the development of Type 1 diabetes in mice. By depleting B cells, regulators of the immune system rise, allowing T regulatory cells to function properly and making killer T cells tolerant of insulin-producing cells.
A study found that stem cell transplantation significantly increased C-peptide levels and improved glycemic control in patients with type 1 diabetes, leading to prolonged insulin independence. The treatment has the potential to reverse type 1 DM in humans, but further studies are needed to confirm its role.
Scientists from the University of Cambridge discovered four rare genetic mutations that reduce the risk of developing type 1 diabetes, a link between T1D and enterovirus infections established. The IFIH1 gene variants were found to protect against T1D by reducing immune activation caused by enterovirus infections.
A new study found that over 60% of pancreases from children with type 1 diabetes showed evidence of enteroviral infection, suggesting a potential link between viruses and the disease. The research suggests that enteroviral infection may trigger an immune response that destroys beta cells in the pancreas.
The SEARCH for diabetes in youth study found alarmingly high rates of diabetes among every racial and ethnic group. Type 1 diabetes is more common than previously reported in Hispanic and African-American youth, while type 2 diabetes is more prevalent in Asian/Pacific Islanders.
JDRF-funded researchers have identified compounds that can stimulate insulin-producing cells in the pancreas, paving the way for potential regenerative medicines for type 1 diabetes. The study found two compounds that promote beta cell replication via different biological pathways.
The Environmental Determinants of Diabetes in the Young (TEDDY) study is expanding to enroll 200 newborns from Georgia and Florida with high-risk genes for type 1 diabetes. Researchers will monitor participants for 15 years, collecting data on genetic and environmental factors that contribute to the disease.
Dr. Wenbo Zhi, a postdoctoral fellow at the Medical College of Georgia, has received a two-year fellowship to study biomarkers associated with type 1 diabetes. He aims to identify protein biomarkers that can improve diagnosis and treatment using proteomic techniques.
Researchers aim to teach the immune system to ignore insulin-producing cells by boosting IDO levels. By enhancing this natural mechanism, they hope to slow or prevent disease progression in high-risk children. A new treatment approach could provide a breakthrough in preventing type 1 diabetes.
Researchers describe a potential new therapeutic approach for diabetic retinopathy using ASP-440, a protease plasma kallikrein inhibitor. The study showed significant reductions in retinal vascular permeability and blood pressure in rodents, suggesting promising results for treating the condition.
JDRF-funded researchers at the University of Pittsburgh School of Medicine discovered a protein called cdk6 that regulates human beta cell replication. This finding provides proof-of-principle for stimulating human beta cell production and function.
A new study published in Value in Health estimates that Americans with diabetes had nearly 22% of hospital charges in 2005, totaling $171 billion. The study also found that individuals with type 1 diabetes were more likely to be hospitalized than those with type 2 diabetes.
Researchers at Albert Einstein College of Medicine developed a technique to make foreign pancreatic cells invisible to the immune system, dramatically protecting them from rejection. The new method could pave the way for routine use of cell transplants as a therapy for type 1 diabetes in humans.
A study from the Norwegian Institute of Public Health found no significant link between human parechovirus infections and typical symptoms in infants. However, researchers noticed an increase in parechovirus infection between 6-18 months, which could be due to factors such as maternal antibody loss or nursery exposure.
A study by researchers at Joslin Diabetes Center found that nearly three-quarters of youths with type 1 diabetes have insufficient levels of vitamin D, which may lead to bone fragility and increased fracture risk. The study recommends vitamin D supplementation to children with diabetes, especially those with inadequate sun exposure and...
Type 1 diabetes and celiac disease share common genetic mechanisms, including autoimmunity-related tissue damage and intolerance to dietary antigens, the study found. Researchers identified seven chromosome regions shared between the two diseases, suggesting a potential link in environmental triggers as well.
A recent study published in Diabetes Care highlights the significant barriers faced by type 1 diabetics when it comes to engaging in physical activity. The researchers found that those with a greater fear of hypoglycemia were also more likely to have poorer diabetes control, emphasizing the need for targeted education and support.
Researchers at UCSF used kinase inhibitors to block and reverse type 1 diabetes in mice, showing potential for new therapeutic approach. The study found that 80% of mice with established diabetes reversed symptoms after two months of treatment.
Researchers found that cancer drugs imatinib and sunitinib can put type 1 diabetes into remission in 80% of test mice. The benefits of the drugs' rapid action are attributed to their ability to block platelet-derived growth factor receptor, a tyrosine kinase not known to be implicated in diabetes.
A population-based study of Type 1 diabetes patients found that better glycemic control reduces diabetic retinopathy progression. Additionally, a cohort study on age-related macular degeneration (AMD) discovered an association between poor night vision and increased risk of AMD progression.
A DNA vaccine, BHT-3021, is being developed to reverse the immune response causing type 1 diabetes. The vaccine has shown safety and preliminary data indicate it may preserve beta cells and induce immune tolerance.